Navrogen
Philadelphia, US · Founded 2017
Biotech
Founders & leadership
NN
Nicholas NicolaidesExecutive Officer, Director
LG
Luigi GrassoExecutive Officer, Director
SG
Steven G KyriakosExecutive Officer
Reported raises · per SEC filings
Form D private placements$542KraisedJun 2024 · 13 investors · Biotechnology
Rule 506(b)$9.1MraisedFeb 2023 · 20 investors · Biotechnology
Rule 506(b)$3.2MraisedSep 2019 · 18 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.